Development of Novel AKR1C3 Inhibitors as New Potential Treatment for Castration-Resistant Prostate Cancer.
Endo S, Oguri H, Segawa J, Kawai M, Hu D, Xia S, Okada T, Irie K, Fujii S, Gouda H, Iguchi K, Matsukawa T, Fujimoto N, Nakayama T, Toyooka N, Matsunaga T, Ikari A.
Endo S, et al. Among authors: matsunaga t.
J Med Chem. 2020 Sep 24;63(18):10396-10411. doi: 10.1021/acs.jmedchem.0c00939. Epub 2020 Sep 9.
J Med Chem. 2020.
PMID: 32847363